🇺🇸 FDA
Pipeline program

Placebo to 100mg masitinib, Placebo to 200mg masitinib, masitinib, masitinib

AB15003

Phase 3 small_molecule active

Quick answer

Placebo to 100mg masitinib, Placebo to 200mg masitinib, masitinib, masitinib for Mastocytosis is a Phase 3 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).

Program details

Company
AB Science
Indication
Mastocytosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials